mycoplasma
pneumonia
pneumonia
one
major
pathogen
caus
commun
acquir
pneumonia
bronchiti
children
treatment
pneumoniaerel
respiratori
infect
base
symptomat
treatment
antibiot
macrolid
use
first
line
treatment
howev
macroliderefractori
pneumonia
mrmp
strain
increas
abruptli
particularli
east
asian
countri
includ
korea
japan
china
patient
mrmp
show
improv
fever
treat
macrolid
may
develop
refractori
sever
clinic
cours
requir
addit
treatment
treatment
mrmp
includ
tetracyclin
fluoroquinolon
system
glucocorticoid
secondari
antibiot
tetracyclin
fluoroquinolon
consid
effect
altern
treatment
mrmp
howev
limit
use
due
safetyconcern
teeth
discolor
musculoskelet
toxic
particularli
children
glucocorticoid
also
consid
altern
treatment
option
due
two
reason
first
pathogenesi
pneumonia
infect
associ
amplifi
host
immun
respons
virul
pneumonia
second
advers
effect
glucocorticoid
well
establish
risk
like
ad
treatment
mrmp
howev
previou
studi
effect
glucocorticoid
shown
conflict
result
object
studi
assess
efficaci
glucocorticoid
treatment
mrmp
children
systemat
review
metaanalysi
perform
systemat
search
util
protocol
design
two
independ
medic
librarian
dw
ml
specif
studi
electron
databas
pubm
embas
cochran
librari
core
journal
korean
japanes
chines
journal
fulltext
databas
search
encompass
articl
publish
januari
march
use
search
term
list
addit
file
search
pubm
cochran
embas
databas
core
countri
impos
languag
public
restrict
first
screen
execut
two
independ
review
hsk
iss
evalu
titl
abstract
obtain
search
record
manag
use
endnot
version
clariv
analyt
philadelphia
pa
usa
initi
screen
articl
focu
glucocorticoid
use
mrmp
review
articl
immedi
exclud
initi
exclus
process
full
text
remain
articl
review
independ
two
author
hsk
iss
determin
whether
articl
met
predetermin
elig
criteria
describ
next
section
disagr
two
review
regard
inclus
exclus
particular
studi
settl
consult
third
review
yjl
follow
inclus
criteria
appli
random
control
trial
rct
compar
efficaci
glucocorticoid
addon
macrolid
alon
children
mrmp
mrmp
diagnos
serolog
polymeras
chain
reaction
refractori
defin
clinic
includ
children
year
age
outcom
measur
hospit
day
fever
durat
level
creactiv
protein
crp
chang
review
articl
publish
abstract
without
fulltext
public
casestudi
report
particip
less
exclud
search
strategi
includ
nonenglish
articl
initi
search
result
nonenglish
articl
translat
includ
evalu
two
review
hsk
iss
independ
screen
titl
abstract
studi
identifi
systemat
search
studi
focus
mrmp
includ
review
abstract
full
text
includ
studi
review
evalu
elig
refer
list
select
studi
previou
review
also
examin
determin
relev
public
overlook
electron
search
disagr
two
review
select
particular
studi
settl
discuss
third
review
yjl
cochran
collabor
risk
bia
tool
use
two
review
hsk
iss
independ
evalu
risk
bia
includ
studi
risk
bia
determin
hi
low
unclear
evalu
random
sequenc
gener
blind
particip
personnel
incomplet
outcom
data
select
report
disagr
two
review
regard
risk
bia
assess
particular
studi
settl
discuss
third
review
yjl
two
review
hsk
iss
use
structur
form
extract
data
elig
studi
data
extract
studi
could
character
characterist
sampl
intervent
detail
measur
outcom
disagr
two
review
regard
data
extract
particular
studi
settl
consult
third
review
yjl
primari
outcom
current
studi
hospit
day
fever
durat
chang
crp
estim
mean
effect
glucocorticoid
addon
treatment
hospit
day
fever
durat
chang
creactiv
protein
crp
associ
confid
interv
ci
extract
calcul
studi
includ
metaanalysi
review
manag
cochran
collabor
london
unit
kingdom
randomeffect
model
use
studi
includ
analysi
heterogen
calcul
use
statist
statist
threshold
alway
interpret
care
rough
estim
denot
low
heterogen
denot
moder
heterogen
denot
high
heterogen
conduct
sensit
analys
heterogen
note
perform
remov
studi
analysi
determin
chang
valu
assess
studi
play
signific
role
result
heterogen
assess
risk
public
bia
use
funnel
plot
visual
inspect
egger
test
trimandfil
method
perform
statist
identifi
statist
analys
perform
use
r
version
review
manag
total
citat
identifi
initi
studi
discard
review
titl
abstract
leav
articl
full
text
review
fig
total
studi
exclud
full
text
review
due
proper
subject
inadequ
studi
protocol
review
articl
relev
outcom
total
studi
includ
systemat
review
metaanalysi
studi
rct
addit
file
search
strategi
databas
addit
file
prisma
checklist
particip
studi
enrol
metaanalysi
total
patient
studi
examin
fever
durat
fifteen
studi
examin
hospit
day
studi
examin
crp
level
treatment
tabl
mean
length
total
durat
fever
significantli
shorter
glucocorticoid
addon
group
convent
treatment
group
weight
mean
differ
wmd
ci
z
p
howev
high
betweenstudi
heterogen
effect
fig
mean
length
hospit
stay
glucocorticoid
addon
treatment
group
significantli
shorter
convent
treatment
group
wmd
ci
z
p
howev
high
betweenstudi
heterogen
effect
fig
level
crp
treatment
significantli
lower
glucocorticoid
addon
treatment
group
convent
treatment
group
wmd
ci
z
p
howev
high
betweenstudi
heterogen
effect
fig
sensit
analys
perform
high
level
heterogen
remov
studi
analysi
determin
studi
contribut
significantli
heterogen
determin
chang
valu
found
valu
fever
durat
hospit
day
crp
level
chang
use
glucocorticoid
includ
use
type
glucocorticoid
eg
methylprednisolon
dexamethason
prednisolon
use
differ
type
glucocorticoid
differ
across
studi
might
contribut
heterogen
overal
use
glucocorticoid
thu
stratifi
metaanalysi
subgroup
analys
subgroup
metaanalysi
use
methylprednisolon
compar
use
glucocorticoid
length
hospit
stay
use
steroid
show
signific
subgroup
differ
fig
funnel
plot
symmetr
indic
absenc
signific
public
bia
within
studi
except
crp
outcom
egger
test
result
p
fever
durat
p
hospit
day
p
crp
trimandfil
method
adjust
public
bia
crp
outcom
perform
mean
differ
chang
p
p
result
indic
substanti
evid
public
bia
crp
outcom
fig
systemat
review
metaanalysi
identifi
assess
rct
use
glucocorticoid
children
mrmp
specif
investig
effect
glucocorticoid
fever
durat
length
hospit
stay
crp
level
treatment
comparison
convent
macrolid
therapi
result
reveal
posit
effect
glucocorticoid
treatment
outcom
measur
pneumonia
common
pathogen
caus
commun
acquir
pneumonia
clinic
cours
pneumonia
infect
divers
rang
selflimit
sever
pneumonia
extrapulmonari
complic
macrolid
consid
firstlin
treatment
pneumonia
infect
adult
one
studi
report
prednison
treatment
day
patient
communityacquir
pneumonia
admit
hospit
shorten
time
clinic
stabil
without
increas
complic
howev
anoth
studi
report
glucocorticoid
use
show
benefit
children
pulmonari
injuri
associ
sever
mycoplasma
pneumonia
could
caus
host
immun
respons
rather
direct
microbi
damag
overli
activ
cellmedi
immun
cytokin
respons
play
signific
role
mrmp
sever
pneumonia
infect
mrmp
show
similar
laboratori
find
sever
acut
respiratori
syndrom
increas
level
nonspecif
marker
inflamm
serum
crp
lactat
dehydrogenas
ddimer
sinc
mrmp
consid
immunemedi
diseas
use
immun
modulatori
therapi
could
seem
ration
case
mrmp
infect
secondari
treatment
option
limit
due
advers
effect
tetracyclin
fluoroquinolon
especi
children
use
system
steroid
addit
antimicrobi
therapi
diminish
host
immun
respons
mrmp
use
children
demonstr
satisfactori
effect
glucocorticoid
shown
improv
clinic
featur
reduc
lung
injuri
children
adult
use
glucocorticoid
pneumonia
infect
show
reduc
lung
histopatholog
score
reduc
cytokin
decreas
inflammatori
respons
ultim
lead
lower
mortal
therefor
glucocorticoid
consid
suitabl
adjunct
therapi
macrolid
therapi
although
previou
studi
report
efficaci
glucocorticoid
treatment
sever
mrmp
treatment
protocol
vari
oral
prednisolon
mgkgday
intraven
methylprednisolon
mgkgday
day
variabl
treatment
protocol
due
lack
guidelin
glucocorticoid
treatment
sever
mrmp
date
studi
mean
length
total
durat
fever
mean
length
hospit
stay
level
crp
treatment
glucocorticoid
treatment
group
significantli
shorter
lower
convent
treatment
group
howev
heterogen
outcom
measur
high
sensit
analysi
result
signific
differ
subgroup
analysi
show
signific
decreas
heterogen
spite
high
level
heterogen
studi
report
favor
outcom
hospit
stay
fever
durat
use
glucocorticoid
mrmp
crp
level
one
studi
report
unfavor
result
use
glucocorticoid
mrmp
therefor
could
consid
use
glucocorticoid
significantli
favor
effect
outcom
mrmp
strength
review
summar
current
evid
efficaci
glucocorticoid
rct
conduct
rct
offer
potenti
produc
definit
evid
confirm
refut
whether
glucocorticoid
help
improv
outcom
mrmp
review
limit
firstli
almost
studi
includ
review
least
one
methodolog
flaw
secondli
public
bia
signific
chang
crp
level
might
due
small
sampl
size
studi
fact
studi
conduct
singl
countri
result
robust
outcom
explor
futur
studi
thirdli
studi
includ
singl
countri
lastli
could
evalu
outcom
improv
chest
xray
infiltr
symptom
cough
data
avail
studi
despit
limit
review
metaanalysi
first
studi
date
synthes
efficaci
glucocorticoid
mrmp
conclus
even
though
studi
report
efficaci
effect
system
glucocorticoid
treatment
mrmp
first
systemat
review
metaanalysi
investig
effect
glucocorticoid
mrmp
found
use
glucocorticoid
could
shorten
hospit
day
shorten
fever
durat
lower
crp
level
treatment
howev
result
interpret
cautious
futur
studi
also
assess
outcom
clarifi
effect
glucocorticoid
mrmp
